Skip to content

Clinical trials

Phase 1/2 Neutropenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 1/2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20081
20103
20121
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)2
Children's Hospital Los Angeles1
Children's Hospital of Philadelphia1
Egetis Therapeutics1
National Cancer Institute (NCI)1
National Institute of Allergy and Infectious Diseases (NIAID)1
Pfizer1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia9
Anemia, Aplastic2
Febrile Neutropenia2
Infections2
Pancytopenia2
Agammaglobulinemia1
Anemia1
Anemia, Dyserythropoietic, Congenital1
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.